AMERICAN HEALTHCARE REIT INC (AHR) Fundamental Analysis & Valuation

NYSE:AHR • US3981823038

Current stock price

48.09 USD
+0.57 (+1.2%)
At close:
48.09 USD
0 (0%)
After Hours:

This AHR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. AHR Profitability Analysis

1.1 Basic Checks

  • In the past year AHR was profitable.
  • AHR had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: AHR reported negative net income in multiple years.
  • In the past 5 years AHR always reported a positive cash flow from operatings.
AHR Yearly Net Income VS EBIT VS OCF VS FCFAHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M

1.2 Ratios

  • AHR has a Return On Assets (-0.23%) which is in line with its industry peers.
  • AHR has a Return On Equity of -0.95%. This is comparable to the rest of the industry: AHR outperforms 40.98% of its industry peers.
  • AHR has a Return On Invested Capital (3.05%) which is comparable to the rest of the industry.
  • The Average Return On Invested Capital over the past 3 years for AHR is in line with the industry average of 3.11%.
  • The 3 year average ROIC (2.69%) for AHR is below the current ROIC(3.05%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.23%
ROE -0.95%
ROIC 3.05%
ROA(3y)0.2%
ROA(5y)0.79%
ROE(3y)0.69%
ROE(5y)2.74%
ROIC(3y)2.69%
ROIC(5y)2.5%
AHR Yearly ROA, ROE, ROICAHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

1.3 Margins

  • AHR has a Operating Margin (28.52%) which is in line with its industry peers.
  • In the last couple of years the Operating Margin of AHR has grown nicely.
  • Looking at the Gross Margin, with a value of 67.74%, AHR is in line with its industry, outperforming 51.64% of the companies in the same industry.
  • In the last couple of years the Gross Margin of AHR has grown nicely.
Industry RankSector Rank
OM 28.52%
PM (TTM) N/A
GM 67.74%
OM growth 3Y26.16%
OM growth 5Y20.2%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.89%
GM growth 5Y17.28%
AHR Yearly Profit, Operating, Gross MarginsAHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. AHR Health Analysis

2.1 Basic Checks

  • AHR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • AHR has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for AHR has been increased compared to 5 years ago.
  • The debt/assets ratio for AHR is higher compared to a year ago.
AHR Yearly Shares OutstandingAHR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
AHR Yearly Total Debt VS Total AssetsAHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • Based on the Altman-Z score of 1.42, we must say that AHR is in the distress zone and has some risk of bankruptcy.
  • AHR has a better Altman-Z score (1.42) than 89.34% of its industry peers.
  • AHR has a Debt/Equity ratio of 1.91. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 1.91, AHR is not doing good in the industry: 67.21% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.91
Debt/FCF N/A
Altman-Z 1.42
ROIC/WACC0.39
WACC7.79%
AHR Yearly LT Debt VS Equity VS FCFAHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • A Current Ratio of 0.24 indicates that AHR may have some problems paying its short term obligations.
  • AHR has a Current ratio of 0.24. This is amonst the worse of the industry: AHR underperforms 86.89% of its industry peers.
  • AHR has a Quick Ratio of 0.24. This is a bad value and indicates that AHR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.23, AHR is doing worse than 83.61% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.24
Quick Ratio 0.23
AHR Yearly Current Assets VS Current LiabilitesAHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. AHR Growth Analysis

3.1 Past

  • AHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.76%, which is quite good.
  • The Revenue for AHR has decreased by -59.74% in the past year. This is quite bad
  • The Revenue has been decreasing by -5.76% on average over the past years.
EPS 1Y (TTM)11.76%
EPS 3Y-25.79%
EPS 5Y0%
EPS Q2Q%11.54%
Revenue 1Y (TTM)-59.74%
Revenue growth 3Y-14.37%
Revenue growth 5Y-5.76%
Sales Q2Q%-86.74%

3.2 Future

  • Based on estimates for the next years, AHR will show a very strong growth in Earnings Per Share. The EPS will grow by 44.28% on average per year.
  • AHR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 78.98% yearly.
EPS Next Y-67.79%
EPS Next 2Y-32.45%
EPS Next 3Y44.28%
EPS Next 5YN/A
Revenue Next Year4.97%
Revenue Next 2Y5.36%
Revenue Next 3Y4.37%
Revenue Next 5Y78.98%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AHR Yearly Revenue VS EstimatesAHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
AHR Yearly EPS VS EstimatesAHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 0.4 0.6 0.8 1

More info and screens

Find the best growth stocksShow best growing peers

1

4. AHR Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 126.55, the valuation of AHR can be described as expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of AHR is on the same level as its industry peers.
  • AHR's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 25.60.
  • With a Price/Forward Earnings ratio of 392.89, AHR can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Forward Earnings ratio as AHR.
  • AHR's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.84.
Industry RankSector Rank
PE 126.55
Fwd PE 392.89
AHR Price Earnings VS Forward Price EarningsAHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

  • AHR's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. AHR is more expensive than 91.80% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 37.94
AHR Per share dataAHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • AHR's earnings are expected to grow with 44.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-32.45%
EPS Next 3Y44.28%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

1

5. AHR Dividend Analysis

5.1 Amount

  • AHR has a Yearly Dividend Yield of 2.12%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 7.55, AHR's dividend is way lower than its industry peers. On top of this 86.07% of the companies listed in the same industry pay a better dividend than AHR!
  • AHR's Dividend Yield is comparable with the S&P500 average which is at 1.90.
Industry RankSector Rank
Dividend Yield 2.12%

5.2 History

  • AHR has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
AHR Yearly Dividends per shareAHR Yearly Dividends per shareYearly Dividends per share 2024 2025 2026 0.2 0.4 0.6 0.8

5.3 Sustainability

  • AHR has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-1265.55%
EPS Next 2Y-32.45%
EPS Next 3Y44.28%
AHR Yearly Income VS Free CF VS DividendAHR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M

More info and screens

Find the best dividend stocksShow peers with best dividend

AHR Fundamentals: All Metrics, Ratios and Statistics

AMERICAN HEALTHCARE REIT INC

NYSE:AHR (4/2/2026, 8:07:26 PM)

After market: 48.09 0 (0%)

48.09

+0.57 (+1.2%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-16
Earnings (Next)05-05
Inst Owners78.11%
Inst Owner Change15.14%
Ins Owners0.63%
Ins Owner Change-1.94%
Market Cap4.99B
Revenue(TTM)285.20M
Net Income(TTM)-5.94M
Analysts80
Price Target59.24 (23.19%)
Short Float %27.72%
Short Ratio6.95
Dividend
Industry RankSector Rank
Dividend Yield 2.12%
Yearly Dividend1.08
Dividend Growth(5Y)N/A
DP-1265.55%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-31
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)211.82%
Min EPS beat(2)-187.15%
Max EPS beat(2)610.78%
EPS beat(4)2
Avg EPS beat(4)120.69%
Min EPS beat(4)-345.1%
Max EPS beat(4)610.78%
EPS beat(8)4
Avg EPS beat(8)192.99%
EPS beat(12)5
Avg EPS beat(12)80.89%
EPS beat(16)9
Avg EPS beat(16)93.59%
Revenue beat(2)2
Avg Revenue beat(2)1.69%
Min Revenue beat(2)0.58%
Max Revenue beat(2)2.79%
Revenue beat(4)4
Avg Revenue beat(4)366.94%
Min Revenue beat(4)0.58%
Max Revenue beat(4)738.85%
Revenue beat(8)8
Avg Revenue beat(8)532.61%
Revenue beat(12)12
Avg Revenue beat(12)450.59%
Revenue beat(16)16
Avg Revenue beat(16)365.86%
PT rev (1m)3.57%
PT rev (3m)3.55%
EPS NQ rev (1m)-100%
EPS NQ rev (3m)-100%
EPS NY rev (1m)-83.26%
EPS NY rev (3m)-83.31%
Revenue NQ rev (1m)-89.02%
Revenue NQ rev (3m)-88.56%
Revenue NY rev (1m)-88.61%
Revenue NY rev (3m)-88.33%
Valuation
Industry RankSector Rank
PE 126.55
Fwd PE 392.89
P/S 17.48
P/FCF N/A
P/OCF 77.61
P/B 7.94
P/tB 9.06
EV/EBITDA 37.94
EPS(TTM)0.38
EY0.79%
EPS(NY)0.12
Fwd EY0.25%
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)0.62
OCFY1.29%
SpS2.75
BVpS6.05
TBVpS5.31
PEG (NY)N/A
PEG (5Y)N/A
Graham Number7.2
Profitability
Industry RankSector Rank
ROA -0.23%
ROE -0.95%
ROCE 3.86%
ROIC 3.05%
ROICexc 3.13%
ROICexgc 3.34%
OM 28.52%
PM (TTM) N/A
GM 67.74%
FCFM N/A
ROA(3y)0.2%
ROA(5y)0.79%
ROE(3y)0.69%
ROE(5y)2.74%
ROIC(3y)2.69%
ROIC(5y)2.5%
ROICexc(3y)2.76%
ROICexc(5y)2.56%
ROICexgc(3y)2.95%
ROICexgc(5y)2.74%
ROCE(3y)3.4%
ROCE(5y)3.17%
ROICexgc growth 3Y6.79%
ROICexgc growth 5Y8.56%
ROICexc growth 3Y7.57%
ROICexc growth 5Y8.47%
OM growth 3Y26.16%
OM growth 5Y20.2%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.89%
GM growth 5Y17.28%
F-Score5
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 1.91
Debt/FCF N/A
Debt/EBITDA 6.94
Cap/Depr 98.96%
Cap/Sales 31.75%
Interest Coverage 1.11
Cash Conversion 37.18%
Profit Quality N/A
Current Ratio 0.24
Quick Ratio 0.23
Altman-Z 1.42
F-Score5
WACC7.79%
ROIC/WACC0.39
Cap/Depr(3y)86.46%
Cap/Depr(5y)148.77%
Cap/Sales(3y)29.96%
Cap/Sales(5y)37.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.76%
EPS 3Y-25.79%
EPS 5Y0%
EPS Q2Q%11.54%
EPS Next Y-67.79%
EPS Next 2Y-32.45%
EPS Next 3Y44.28%
EPS Next 5YN/A
Revenue 1Y (TTM)-59.74%
Revenue growth 3Y-14.37%
Revenue growth 5Y-5.76%
Sales Q2Q%-86.74%
Revenue Next Year4.97%
Revenue Next 2Y5.36%
Revenue Next 3Y4.37%
Revenue Next 5Y78.98%
EBIT growth 1Y-12.01%
EBIT growth 3Y8.03%
EBIT growth 5Y13.28%
EBIT Next Year171.97%
EBIT Next 3Y39.68%
EBIT Next 5YN/A
FCF growth 1Y-150.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-42.65%
OCF growth 3Y-18.09%
OCF growth 5Y-6.77%

AMERICAN HEALTHCARE REIT INC / AHR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of AMERICAN HEALTHCARE REIT INC (AHR) stock?

ChartMill assigns a fundamental rating of 3 / 10 to AHR.


What is the valuation status of AMERICAN HEALTHCARE REIT INC (AHR) stock?

ChartMill assigns a valuation rating of 1 / 10 to AMERICAN HEALTHCARE REIT INC (AHR). This can be considered as Overvalued.


How profitable is AMERICAN HEALTHCARE REIT INC (AHR) stock?

AMERICAN HEALTHCARE REIT INC (AHR) has a profitability rating of 5 / 10.


What is the valuation of AMERICAN HEALTHCARE REIT INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for AMERICAN HEALTHCARE REIT INC (AHR) is 126.55 and the Price/Book (PB) ratio is 7.94.


What is the financial health of AMERICAN HEALTHCARE REIT INC (AHR) stock?

The financial health rating of AMERICAN HEALTHCARE REIT INC (AHR) is 1 / 10.